相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
Hao Zhang et al.
BONE MARROW TRANSPLANTATION (2020)
Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report
Ze-Fa Liu et al.
BIOMARKER RESEARCH (2020)
Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia
Lamis K. Eldjerou et al.
BLOOD (2019)
Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses
Colleen Annesley et al.
BLOOD (2019)
Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Xinjie Xu et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Chimeric antigen receptor-modified T cells: CD19 and the road beyond
Alexander I. Salter et al.
BLOOD (2018)
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
Jianyu Weng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia
Elad Jacoby et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia
Ibrahim Aldoss et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Updates in the biology and therapy for infant acute lymphoblastic leukemia
Erin M. Guest et al.
CURRENT OPINION IN PEDIATRICS (2017)
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E. M. C. Driessen et al.
LEUKEMIA (2016)
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Rebecca Gardner et al.
BLOOD (2016)
FDG-PET/CT for Detection of Extramedullary Disease in 2 Pediatric Patients With AML
Motohiro Matsui et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2016)
Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy
Ahmad Rayes et al.
PEDIATRIC BLOOD & CANCER (2016)
Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL
Shannon L. Maude et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
Hanren Dai et al.
ONCOIMMUNOLOGY (2015)
Extramedullary disease in patients with acute myeloid leukemia assessed by (18)F-FDG PET
Anne-Sofie Weindel Ibar Cribe et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Relapsed childhood acute lymphoblastic leukaemia
Deepa Bhojwani et al.
LANCET ONCOLOGY (2013)
How I treat relapsed childhood acute lymphoblastic leukemia
Franco Locatelli et al.
BLOOD (2012)
Isolated Renal Relapse in Acute Lymphoblastic Leukemia
Aliva De et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
K. Nguyen et al.
LEUKEMIA (2008)
Extramedullary relapse of acute lymphoblastic leukemia in childhood to the prostate
Takuo Maruyama et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
分享论文
